| KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation SJ Chadban, C Ahn, DA Axelrod, BJ Foster, BL Kasiske, V Kher, D Kumar, ... Transplantation 104 (4S1), S11-S103, 2020 | 422 | 2020 |
| Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II–induced inflammation M Jurewicz, DH McDermott, JM Sechler, K Tinckam, A Takakura, ... Journal of the American Society of Nephrology 18 (4), 1093-1102, 2007 | 267 | 2007 |
| Delayed graft function and the risk for death with a functioning graft SN Tapiawala, KJ Tinckam, CJ Cardella, J Schiff, DC Cattran, EH Cole, ... Journal of the American society of nephrology 21 (1), 153-161, 2010 | 249 | 2010 |
| Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report AR Tambur, P Campbell, FH Claas, S Feng, HM Gebel, AM Jackson, ... American Journal of Transplantation 18 (7), 1604-1614, 2018 | 234 | 2018 |
| The profile of cardiac patients with renal artery stenosis CE Buller, JG Nogareda, K Ramanathan, DR Ricci, O Djurdjev, ... Journal of the American College of Cardiology 43 (9), 1606-1613, 2004 | 225 | 2004 |
| The role of donor-specific HLA alloantibodies in liver transplantation JG O’leary, AJ Demetris, LS Friedman, HM Gebel, PF Halloran, AD Kirk, ... American Journal of Transplantation 14 (4), 779-787, 2014 | 212 | 2014 |
| Utility of HLA antibody testing in kidney transplantation A Konvalinka, K Tinckam Journal of the American Society of Nephrology 26 (7), 1489-1502, 2015 | 194 | 2015 |
| Adverse outcomes of tacrolimus withdrawal in immune–quiescent kidney transplant recipients DE Hricik, RN Formica, P Nickerson, D Rush, RL Fairchild, ED Poggio, ... Journal of the American Society of Nephrology 26 (12), 3114-3122, 2015 | 193 | 2015 |
| Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status KJ Tinckam, O Djurdjev, AB Magil Kidney international 68 (4), 1866-1874, 2005 | 165 | 2005 |
| Kidney paired donation: principles, protocols and programs P Ferrari, W Weimar, RJ Johnson, WH Lim, KJ Tinckam Nephrology Dialysis Transplantation 30 (8), 1276-1285, 2015 | 157 | 2015 |
| Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection AB Magil, K Tinckam Kidney international 63 (5), 1888-1893, 2003 | 153 | 2003 |
| De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation JM Tikkanen, LG Singer, SJ Kim, Y Li, M Binnie, C Chaparro, CW Chow, ... American journal of respiratory and critical care medicine 194 (5), 596-606, 2016 | 151 | 2016 |
| Survival in sensitized lung transplant recipients with perioperative desensitization KJ Tinckam, S Keshavjee, C Chaparro, D Barth, S Azad, M Binnie, ... American Journal of Transplantation 15 (2), 417-426, 2015 | 145 | 2015 |
| HLA-DR and-DQ eplet mismatches and transplant glomerulopathy: a nested case–control study R Sapir-Pichhadze, K Tinckam, K Quach, AG Logan, A Laupacis, R John, ... American journal of transplantation 15 (1), 137-148, 2015 | 143 | 2015 |
| Mechanisms and role of HLA and non-HLA alloantibodies KJ Tinckam, A Chandraker Clinical Journal of the American Society of Nephrology 1 (3), 404-414, 2006 | 102 | 2006 |
| Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high‐resolution rather than the antigen level? RJ Duquesnoy, M Kamoun, LA Baxter‐Lowe, ES Woodle, RA Bray, ... American journal of transplantation 15 (4), 923-930, 2015 | 91 | 2015 |
| The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology K Tinckam, D Rush, I Hutchinson, I Dembinski, V Pravica, J Jeffery, ... Transplantation 79 (7), 836-841, 2005 | 91 | 2005 |
| Summary of the kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and management of candidates for kidney transplantation SJ Chadban, C Ahn, DA Axelrod, BJ Foster, BL Kasiske, V Kher, D Kumar, ... Transplantation 104 (4), 708-714, 2020 | 86 | 2020 |
| Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study JJ Feld, M Cypel, D Kumar, H Dahari, RVP Ribeiro, N Marks, N Kamkar, ... The Lancet Gastroenterology & Hepatology 5 (7), 649-657, 2020 | 81 | 2020 |
| Survival analysis in the presence of competing risks: the example of waitlisted kidney transplant candidates R Sapir‐Pichhadze, M Pintilie, KJ Tinckam, A Laupacis, AG Logan, ... American Journal of Transplantation 16 (7), 1958-1966, 2016 | 80 | 2016 |
